112 related articles for article (PubMed ID: 11174594)
1. Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.
Streckfus C; Bigler L; Dellinger T; Dai X; Cox WJ; McArthur A; Kingman A; Thigpen JT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):174-9. PubMed ID: 11174594
[TBL] [Abstract][Full Text] [Related]
2. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
[TBL] [Abstract][Full Text] [Related]
3. The potential use of saliva to detect recurrence of disease in women with breast carcinoma.
Bigler LR; Streckfus CF; Copeland L; Burns R; Dai X; Kuhn M; Martin P; Bigler SA
J Oral Pathol Med; 2002 Aug; 31(7):421-31. PubMed ID: 12165061
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma.
Streckfus C; Bigler L; Tucci M; Thigpen JT
Cancer Invest; 2000; 18(2):101-9. PubMed ID: 10705871
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive usage and the expression of CA 15-3 and c-erbB-2 in the saliva of healthy women.
McIntyre R; Bigler L; Dellinger T; Pfeifer M; Mannery T; Streckfus C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Dec; 88(6):687-90. PubMed ID: 10625851
[TBL] [Abstract][Full Text] [Related]
6. CA 15-3 and c-erbB-2 presence in the saliva of women.
Streckfus C; Bigler L; Dellinger T; Pfeifer M; Rose A; Thigpen JT
Clin Oral Investig; 1999 Sep; 3(3):138-43. PubMed ID: 10803125
[TBL] [Abstract][Full Text] [Related]
7. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study.
Streckfus C; Bigler L
Adv Dent Res; 2005 Jun; 18(1):17-24. PubMed ID: 15998939
[TBL] [Abstract][Full Text] [Related]
8. The expression of the c-erbB-2 receptor protein in glandular salivary secretions.
Streckfus CF; Bigler L; Dellinger T; Kuhn M; Chouinard N; Dai X
J Oral Pathol Med; 2004 Nov; 33(10):595-600. PubMed ID: 15482325
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and salivary C-erbB-2, CEA and CA15-3 in healthy women: a case-control study.
Vahedi M; Abdollahzadeh S; Vaziri PB; Mortazavi H
Med Oral Patol Oral Cir Bucal; 2011 Jan; 16(1):e29-32. PubMed ID: 20711149
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
11. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
12. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?
Pierce LJ; Merino MJ; D'Angelo T; Barker EA; Gilbert L; Cowan KH; Steinberg SM; Glatstein E
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):395-403. PubMed ID: 7903962
[TBL] [Abstract][Full Text] [Related]
13. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects.
Katakura A; Kamiyama I; Takano N; Shibahara T; Muramatsu T; Ishihara K; Takagi R; Shouno T
Bull Tokyo Dent Coll; 2007 Nov; 48(4):199-203. PubMed ID: 18360107
[TBL] [Abstract][Full Text] [Related]
14. Physiologic determinants of endothelin concentrations in human saliva.
Xiang S; Denver R; Bailey M; Krum H
Clin Chem; 2003 Dec; 49(12):2012-9. PubMed ID: 14633872
[TBL] [Abstract][Full Text] [Related]
15. Saliva collection devices affect sex steroid concentrations.
Celec P; Ostatníková D
Clin Chim Acta; 2012 Oct; 413(19-20):1625-8. PubMed ID: 22579929
[TBL] [Abstract][Full Text] [Related]
16. Sample volume matters when sampling saliva in paediatric clinical analysis.
Mörelius E; Theodorsson E; Nelson N
Acta Paediatr; 2013 Sep; 102(9):e389. PubMed ID: 23692503
[No Abstract] [Full Text] [Related]
17. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study.
Streckfus CF; Bigler LR; Zwick M
J Oral Pathol Med; 2006 May; 35(5):292-300. PubMed ID: 16630293
[TBL] [Abstract][Full Text] [Related]
18. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation in saliva estriol level during pregnancy: a pilot study.
McGregor JA; Hastings C; Roberts T; Barrett J
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 3):S223-5. PubMed ID: 9914622
[TBL] [Abstract][Full Text] [Related]
20. Validation of an LC-MS/MS salivary assay for glucocorticoid status assessment: Evaluation of the diurnal fluctuation of cortisol and cortisone and of their association within and between serum and saliva.
Mezzullo M; Fanelli F; Fazzini A; Gambineri A; Vicennati V; Di Dalmazi G; Pelusi C; Mazza R; Pagotto U; Pasquali R
J Steroid Biochem Mol Biol; 2016 Oct; 163():103-12. PubMed ID: 27108942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
